# CORRESP — HCW Biologics Inc.  (HCWB)  (CIK 0001828673)

> <strong>HCW Biologics Inc.  (HCWB)  (CIK 0001828673) → SEC staff</strong> · filed 2026-02-11 · ticker HCWB · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001193125-26-047334
- **Form:** CORRESP
- **Filer:** HCW Biologics Inc.  (HCWB)  (CIK 0001828673)
- **CIK:** 0001828673
- **Ticker:** HCWB
- **Filed:** 2026-02-11
- **SIC industry:** 2834
- **HQ:** Miramar, FL

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1828673/000119312526047334/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1828673&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for HCW Biologics Inc.  (HCWB)  (CIK 0001828673)

- CORRESP — 2026-08-28 — /comment-letter/0001493152-26-040624
- UPLOAD — 2026-08-26 — /comment-letter/0000000000-26-008417
- CORRESP — 2026-06-16 — /comment-letter/0001493152-26-028858
- UPLOAD — 2026-06-12 — /comment-letter/0000000000-26-005926
- CORRESP — 2026-02-11 — /comment-letter/0001193125-26-047207

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, HCW Biologics Inc.  (HCWB)  (CIK 0001828673) (CIK 0001828673), filed 2026-02-11, accession 0001193125-26-047334. Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/comment-letter/0001193125-26-047334.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*